Compare HNVR & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HNVR | EDAP |
|---|---|---|
| Founded | 2008 | 1979 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.5M | 163.4M |
| IPO Year | 2022 | 1998 |
| Metric | HNVR | EDAP |
|---|---|---|
| Price | $22.63 | $3.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $24.50 | $10.00 |
| AVG Volume (30 Days) | 6.8K | ★ 32.7K |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.77% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.00 | N/A |
| Revenue | N/A | ★ $70,527,000.00 |
| Revenue This Year | $35.49 | N/A |
| Revenue Next Year | $8.61 | $6.13 |
| P/E Ratio | $22.60 | ★ N/A |
| Revenue Growth | N/A | ★ 1.63 |
| 52 Week Low | $19.91 | $1.21 |
| 52 Week High | $24.36 | $5.05 |
| Indicator | HNVR | EDAP |
|---|---|---|
| Relative Strength Index (RSI) | 62.27 | 42.03 |
| Support Level | $21.58 | $3.19 |
| Resistance Level | $23.66 | $3.44 |
| Average True Range (ATR) | 0.35 | 0.25 |
| MACD | 0.08 | 0.03 |
| Stochastic Oscillator | 69.59 | 47.70 |
Hanover Bancorp Inc is a community commercial bank focused on providing personalized and efficient services and products tailored to local needs. The Bank offers a full range of financial services, including a complete suite of consumer, commercial, and municipal banking products such as multifamily and commercial mortgages, government-guaranteed loans, residential loans, business loans, and lines of credit. In addition, it provides customers with access to 24-hour ATM services with no fees, interest-bearing free checking accounts, telephone banking, mobile and internet banking solutions for both consumer and business clients, and safe deposit boxes.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.